Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Q3 2024 Earnings Call Transcript
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Q3 2024 Earnings Call Transcript October 29, 2024Harmony Biosciences Holdings, Inc. beats earnings expectations.
Harmony Biosciences Holdings Inc. (HRMY)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Vivo Capital Albert Cha And Frank Kung | 2,606,247 | $104,249,880 | 8.62% | |
| 2. | Renaissance Technologies Jim Simons | 492,600 | $19,704,000 | -18% | 0.02% |
| 3. | Cutter Capital Vince Aita | 376,315 | $15,052,600 | +28% | 4.44% |
| 4. | D E Shaw D. E. Shaw | 355,949 | $14,237,960 | +15% | 0.01% |
| 5. | Marshall Wace LLP Paul Marshall And Ian Wace | 350,641 | $14,025,640 | +15% | 0.01% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $24.00 | 339,476 | Large Shareholder | 10,651,120 | 2020-08-21 | Filing | |
| $34.30 | 3,922 | Director | 42,702 | 2020-08-26 | Filing | |
| $34.20 | 823 | Director | 38,780 | 2020-08-25 | Filing | |
| $24.00 | 132,503 | Large Shareholder | 4,409,803 | 2020-08-21 | Filing | |
| $34.30 | 3,057 | Director | 37,957 | 2020-08-24 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $30.30 | 600,000 | Large Shareholder | 6,618,033 | 2024-11-05 | Filing | |
| $30.30 | 4,000,000 | Large Shareholder | 7,218,033 | 2024-11-01 | Filing | |
| $30.30 | 600,000 | Large Shareholder | 6,051,120 | 2024-11-05 | Filing | |
| $30.30 | 4,000,000 | Large Shareholder | 6,651,120 | 2024-11-01 | Filing | |
| $40.47 | 21,496 | 0 | 2024-10-29 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 11,218,033 | $362,342,466 | 99.55% | |
| 2. | 6,003,327 | $193,907,461 | 0% | |
| 3. | 5,276,825 | $170,441,447 | 0.01% | |
| 4. | 3,674,764 | $118,694,878 | 0% | |
| 5. | 1,360,447 | $43,942,438 | 0% |
News See All
Piper Sandler's Top Technical Stock Picks: 20 Best Stocks
The start of October has seen another wild swing for markets. September's second half saw Wall Street rejoice as the Federal Reserve delivered its highly anticipated interest rate cut.
8 Most Undervalued Growth Stocks To Buy According To Wall Street Analysts
Analysts and the market blamed the Fed for not cutting the interest rate earlier in July. However, the sentiments seemed to have shifted with the recent jobs report with above-expectation data.
8 Cheap Growth Stocks to Buy According to Analysts
When the Federal Reserve cut rates last week there was a general anticipation that the market would rise. However, that has not been the case.
14 Worst 52-Week High Stocks to Buy According to Short Sellers
The start of the US Federal Reserve cutting cycle ushers a new era in the investment world after one of the longest bull runs.
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Q2 2024 Earnings Call Transcript
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Q2 2024 Earnings Call Transcript August 6, 2024Harmony Biosciences Holdings, Inc. beats earnings expectations.
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Q1 2024 Earnings Call Transcript
Harmony Biosciences Holdings, Inc. beats earnings expectations. Reported EPS is $0.666, expectations were $0.64. Harmony Biosciences Holdings, Inc.
5 Most Undervalued Biotech Stocks To Buy According To Hedge Funds
In this article, we discuss 5 most undervalued biotech stocks to buy according to hedge funds.
10 Biotech Stocks with Huge Potential
In this article, we will take a look at the 10 biotech stocks with huge potential.
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Q4 2023 Earnings Call Transcript
Harmony Biosciences Holdings, Inc. misses on earnings expectations. Reported EPS is $0.45 EPS, expectations were $0.74. Harmony Biosciences Holdings, Inc.